首页> 美国卫生研究院文献>BMJ Open >Effects of dexmedetomidine on delirium and mortality during sedation in ICU patients: a systematic review and meta-analysis protocol
【2h】

Effects of dexmedetomidine on delirium and mortality during sedation in ICU patients: a systematic review and meta-analysis protocol

机译:右美托咪定对ICU患者镇静时del妄和死亡率的影响:系统评价和荟萃分析方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionDelirium is very common in patients admitted to intensive care unit (ICU), and may worsen survival in these patients. Several meta-analyses have evaluated the antidelirium effects of dexmedetomidine in ICU patients, but their findings were inconsistent. Recently, several large multicentre randomised clinical trials (RCTs) were published, but they have not yet to be included in any meta-analysis. We will conduct a meta-analysis adding these data to evaluate the effects of dexmedetomidine on delirium and mortality in ICU patients, aiming to terminate controversy and provide robust evidence for guiding clinical practice.
机译:简介ir妄在重症监护病房(ICU)的患者中很常见,并且可能使这些患者的生存期恶化。几项荟萃分析评估了右美托咪定对ICU患者的抗del妄作用,但发现不一致。最近,发表了几项大型的多中心随机临床试验(RCT),但尚未纳入任何荟萃分析。我们将进行荟萃分析,并添加这些数据以评估右美托咪定对ICU患者的ir妄和死亡率的影响,旨在终止争议并为指导临床实践提供有力证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号